Cure8 research brief
The review links persistent inflammation in IBD to epigenetic changes that could raise colorectal cancer risk and explains why current evidence is not yet ready to change surveillance or prevention practice.
Clinicians and researchers focused on IBD, colorectal cancer prevention, biomarker development, and patients interested in the science behind inflammation-driven cancer risk.
The paper surveys mechanistic evidence that cytokine-driven pathways can alter DNA methylation, chromatin accessibility, and non-coding RNA (microRNA) programs in ways that may persist after inflammation resolves.
Key examples cited include STAT3- and NF-κB–linked effects on DNMT enzymes and specific microRNAs (miR-148a, miR-214) and experimental data showing lasting chromatin accessibility changes in colonic stem cells following colitis.
The authors deliberately separate evidence sources (human CAC/dysplasia, non-neoplastic IBD mucosa, animal inflammation models, sporadic CRC, and cell lines) and rate translational concepts by evidence level.
They outline validation needs for tissue, blood, and stool biomarkers, and propose a roadmap emphasizing single-cell and spatial studies before clinical application.
This is a review article summarizing mechanisms and evidence grades (structured abstract). It emphasizes that no epigenetic biomarker or therapy is currently established for CAC and calls for prospective validation, single-cell and spatial studies.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
People with ulcerative colitis face a higher colorectal cancer risk driven in part by chronic inflammation; this review explains the molecular and immune mechanisms behind that risk and highlights biomarkers and...
The study will prospectively evaluate how often dysplasia occurs, how lesions look and behave after endoscopic resection, and what factors predict local or distant recurrence—information that could change surveillance...
Dysplasia detection during colonoscopy is central to preventing colorectal cancer in people with IBD. AI tools could help, but current models often fail in inflamed or IBD-specific settings, so this review outlines...
